Ensysce Biosciences, Inc. (ENSC) vs Kiora Pharmaceuticals, Inc. (KPRX)

Ensysce Biosciences, Inc. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. Ensysce Biosciences, Inc. and Kiora Pharmaceuticals, Inc. are of similar size ($7.0M and $6.6M). Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against −39.3%. Kiora Pharmaceuticals, Inc. has the higher net margin (0.00% vs −280.5%) and the lower return on invested capital (−44,053.9% vs 0.00%). Across the 16 metrics below, Kiora Pharmaceuticals, Inc. leads on 12 and Ensysce Biosciences, Inc. on 4.

Valuation

Metric ENSC KPRX Biotechnology median
P/E n/m n/m 10.26
P/S 1.01 0.49 9.18
P/B n/m 0.55 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.59 0.65
EV/Sales 1.04 (0.40) 8.98
Earnings yield (788.57%) (166.02%) (34.89%)
Free cash flow yield (194.09%) (93.58%) (24.52%)

Profitability

Metric ENSC KPRX Biotechnology median
Gross margin 100.00% 85.06% 65.16%
Operating margin (281.32%) 0.00% 0.00%
Net margin (280.49%) 0.00% 0.00%
Free cash flow margin (196.76%) 0.00% 0.00%
Return on equity (1,295.01%) (56.36%) (50.12%)
Return on assets (295.92%) (39.43%) (45.60%)
Return on invested capital 0.00% (44,053.91%) 0.00%

Growth

Metric ENSC KPRX Biotechnology median
Revenue growth (TTM) (39.29%) 983.73% 6.26%
EPS growth (last fiscal year) 65.24% (403.45%) 29.88%
Revenue growth, 5-year CAGR 5.21% 88.72% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENSC KPRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.70 8.97 4.89
Net debt to EBITDA 0.42 1.33 1.01

Dividend

Metric ENSC KPRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ENSC KPRX Biotechnology median
Market cap 7.02m 6.63m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack